Broom Colin MD
Insider CIK 1289946 · NBRV Chief Executive Officer, Director · NBRV Chief Executive Officer, Director · NPSP Director · VPHM VP & Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBRV Nabriva Therapeutics plc | S Sale | 2022-08-02 | 2022-08-04 | 5,339 | $0.19 | $1.0K | 36,523 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2021-08-02 | 2021-08-04 | 531 | $1.20 | $637 | 41,862 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2021-07-28 | 2021-07-30 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-07-28 | 2021-07-30 | 17,500 | — | $0 | 42,393 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2020-08-20 | 2020-08-21 | 11,064 | $0.65 | $7.2K | 248,936 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2020-08-19 | 2020-08-21 | 33,750 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2020-08-19 | 2020-08-21 | 33,750 | — | $0 | 260,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-07-29 | 2020-07-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-07-29 | 2020-07-31 | 17,500 | — | $0 | 226,250 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2019-08-30 | 2019-09-03 | 10,177 | $2.03 | $20.7K | 208,750 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2019-08-21 | 2019-08-21 | 10,177 | $2.07 | $21.1K | 125,724 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2019-08-21 | 2019-08-26 | 10,177 | $2.07 | $21.1K | 125,724 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2019-08-19 | 2019-08-21 | 33,750 | — | $0 | 33,750 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2019-08-19 | 2019-08-21 | 33,750 | — | $0 | 135,901 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-07-31 | 2019-08-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-06-22 | 2018-06-25 | 5,000 | $3.72 | $18.6K | 102,151 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-05-23 | 2018-05-23 | 10,000 | $4.60 | $46.0K | 97,151 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 67,500 | — | $0 | 67,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2017-09-22 | 2017-09-26 | 2,588 | $8.35 | $21.6K | 87,151 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 261,000 | — | $0 | 261,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 158,270 | — | $0 | 158,270 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 196,900 | — | $0 | 196,900 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 151,000 | — | $0 | 151,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other | 2017-06-23 | 2017-06-27 | 155,817 | — | $0 | 155,817 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other | 2017-06-23 | 2017-06-27 | 1,595 | — | $0 | 1,595 | SEC↗ |
| NBRV Nabriva Therapeutics AG | A Award deriv | 2017-02-07 | 2017-02-09 | 26,100 | — | $0 | 26,100 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 36,000 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 3,816 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 29,759 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 24,313 | $46.00 | $1.12M | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 3,816 | — | $0 | 3,816 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-02-13 | 2014-02-14 | 15,188 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-02-13 | 2014-02-14 | 15,188 | — | $0 | 24,313 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 4,572 | — | $0 | 4,572 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 40,261 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 32,516 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 34,570 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 35,723 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 27,265 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 40,261 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 40,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 50,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 36,920 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 52,593 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 49,975 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 33,439 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 34,932 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | U Tender | 2014-01-24 | 2014-01-28 | 154,058 | $50.00 | $7.70M | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer | 2014-01-24 | 2014-01-28 | 48,878 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | A Award | 2014-01-24 | 2014-01-28 | 48,878 | — | $0 | 48,878 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 6,561 | — | $0 | 33,439 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 5,068 | — | $0 | 34,932 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 5,025 | — | $0 | 49,975 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 90,000 | — | $0 | 30,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 7,407 | — | $0 | 52,593 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 5,001 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 13,080 | — | $0 | 36,920 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 10,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 2,196 | $49.80 | $109.4K | 151,124 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 6,561 | $15.24 | $100.0K | 153,320 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 2,231 | $49.80 | $111.1K | 146,759 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 7,407 | $13.50 | $100.0K | 148,990 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 1,175 | $49.80 | $58.5K | 141,583 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 13,080 | $8.86 | $115.9K | 136,671 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 1,166 | $49.80 | $58.1K | 137,733 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 5,001 | $9.96 | $49.8K | 138,899 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 5,068 | $19.73 | $100.0K | 156,192 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 2,134 | $49.80 | $106.3K | 154,058 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 90,000 | $1.84 | $165.6K | 122,056 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 6,914 | $49.80 | $344.3K | 115,142 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 10,000 | $5.91 | $59.1K | 125,142 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 1,551 | $49.80 | $77.2K | 123,591 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 5,025 | $9.99 | $50.2K | 142,758 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 2,773 | $49.80 | $138.1K | 133,898 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-06-10 | 2013-06-12 | 32,516 | — | $0 | 32,516 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 15,188 | — | $0 | 15,188 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-02-07 | 2013-02-11 | 6,100 | $8.74 | $53.3K | 9,125 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2013-02-07 | 2013-02-11 | 15,225 | — | $0 | 15,225 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-01-03 | 2013-01-07 | 34,570 | — | $0 | 34,570 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-12-27 | 2012-12-28 | 10,000 | — | $0 | 120,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-12-27 | 2012-12-28 | 10,000 | $1.84 | $18.4K | 30,167 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-12-24 | 2012-12-27 | 17,500 | — | $0 | 112,500 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-12-24 | 2012-12-27 | 17,500 | $1.84 | $32.2K | 55,167 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-12-24 | 2012-12-27 | 17,500 | $22.53 | $394.3K | 37,667 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-12-24 | 2012-12-28 | 17,500 | $22.53 | $394.3K | 20,167 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-12-10 | 2012-12-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-12-10 | 2012-12-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-12-10 | 2012-12-12 | 14,999 | — | $0 | 5,001 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-12-10 | 2012-12-12 | 14,999 | $24.07 | $361.0K | 37,667 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-12-10 | 2012-12-12 | 14,999 | $9.96 | $149.4K | 52,666 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-12-10 | 2012-12-12 | 50,000 | $8.86 | $443.0K | 87,667 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-12-10 | 2012-12-12 | 50,000 | $24.07 | $1.20M | 37,667 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-12-10 | 2012-12-12 | 10,000 | $5.91 | $59.1K | 47,667 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-12-10 | 2012-12-12 | 10,000 | $24.07 | $240.7K | 37,667 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-06-04 | 2012-06-06 | 35,723 | — | $0 | 35,723 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-05-16 | 2012-05-23 | 403 | — | $0 | 29,759 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award | 2012-02-07 | 2012-02-09 | 15,225 | — | $0 | 15,225 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-17 | 2012-01-19 | 2,278 | — | $0 | 29,356 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-01-05 | 2012-01-06 | 27,265 | — | $0 | 27,265 | SEC↗ |